Press "Enter" to skip to content

Recap: Amneal Pharmaceuticals Q2 Earnings

 

Amneal Pharmaceuticals AMRX reported its Q2 earnings results on Friday, August 5, 2022 at 06:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Amneal Pharmaceuticals missed estimated earnings by 5.0%, reporting an EPS of $0.19 versus an estimate of $0.2.

Revenue was up $24.28 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 4.83% drop in the share price the next day.

Here’s a look at Amneal Pharmaceuticals’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.13 0.20 0.20 0.19
EPS Actual 0.12 0.18 0.21 0.25
Revenue Estimate 503.97M 537.35M 545.06M 523.25M
Revenue Actual 497.63M 536.90M 528.59M 535.08M

To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published.